Three named to National Academy of Inventors
Helen Blau, Stanley Cohen and H. Tom Soh are being honored for their work in creating inventions that have improved the quality of life and welfare of society.
Pre-approved drugs tapped for rare eye disease
By identifying proteins abnormally expressed by patients with a rare eye disease, Stanford researchers were able to identify existing drugs that could be used to treat symptoms.
Living with a rare eye disease
One member of an Iowa family with a rare, blinding eye condition described her experience with the disease.
Moms’ blood sugar affects fetal heart
Elevated maternal blood sugar when the fetal heart is forming has been linked to a heightened risk for congenital heart defects, according to a new Stanford study.
Drug for disorder sparks ethical concerns
Medical experts at Stanford and their colleagues at several other universities have raised ethical questions about the way a treatment for spinal muscular atrophy is being used.
Chemotherapy declines for breast cancer
Chemotherapy use for early stage breast cancer declined from 2013 to 2015, possibly due to a preference for less toxic treatments, according to researchers at Stanford and the University of Michigan.
Faculty get funding from stem cell agency
Three Stanford faculty members were awarded $6 million to support research into a blistering skin disease, transplanted stem cells and novel ways to grow blood stem cells.
Faculty members appointed to endowed professorships
Daniel Chang, Howard Chang, Christopher Garcia, Amy Ladd, William Maloney, Geoffrey Tabin and Jerome Yesavage have been appointed to endowed professorships at the School of Medicine.
Stem cells for fat have circadian clock
New discoveries about the circadian-clock machinery in the precursors to fat cells may explain why shift workers are prone to metabolic diseases, such as diabetes, a Stanford study finds.
Second ‘don’t eat me’ signal found on cancer
CD47 is an important inhibitor of cancer-killing immune cells called macrophages. Now Stanford researchers have identified another, similar way to activate macrophages to destroy cancer cells.